APA (7th ed.) Citation

GSD, P., M, C., RA, L., A, B., F, C., M, B., . . . C, T. (2019). Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes. Frontiers in immunology, 10, 571. https://doi.org/10.3389/fimmu.2019.00571

Chicago Style (17th ed.) Citation

GSD, Purvis, et al. "Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes." Frontiers in Immunology 10 (2019): 571. https://doi.org/10.3389/fimmu.2019.00571.

MLA (9th ed.) Citation

GSD, Purvis, et al. "Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes." Frontiers in Immunology, vol. 10, 2019, p. 571, https://doi.org/10.3389/fimmu.2019.00571.